🇺🇸 FDA
Patent

US 11504364

Inhibitors of fibroblast activation protein

granted A61KA61K31/216A61K31/4709

Quick answer

US patent 11504364 (Inhibitors of fibroblast activation protein) held by PRAXIS BIOTECH LLC expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRAXIS BIOTECH LLC
Grant date
Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K31/216, A61K31/4709, A61K45/06, A61P